Sign in

CIK 0001659617 · Non-accelerated filer<br>Smaller reporting company

Moleculin Biotech, Inc.

Sign in to watch
Ticker
MBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474671997
Phone
713-300-5160
Business address
5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
  1. 4 Shares withheld for taxes Chief Science Officer gave up 2,131 shares (to pay taxes)
  2. 4 Shares withheld for taxes CEO and President gave up 7,001 shares (to pay taxes)
  3. 4 Option exercise Chief Financial Officer acquired 5,023 shares (option exercise)
  4. 4 Open-market buy Chief Financial Officer bought 270,270 shares at $0.37 ($100,000)
  5. 4 Open-market buy CEO and President bought 675,675 shares at $0.37 ($250,000)
  6. 4 Shares withheld for taxes Chief Science Officer gave up 693 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 203 shares (to pay taxes)
  8. 4 Shares withheld for taxes CEO and President gave up 406 shares (to pay taxes)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes CEO and President gave up 240 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Science Officer gave up 524 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 1,053 shares (to pay taxes)
  20. 4 Shares withheld for taxes CEO and President gave up 2,190 shares (to pay taxes)

Page 2 of 8 · 143 filings